Impax Labs announced that it has launched its authorized generic version of AstraZeneca's Zomig (zolmitriptan) Tablets and orally disintegrating tablets (2.5 mg and 5 mg)
German, French Indices Vulnerable at Elevated Levels
UCB presented data from a study showing the effect of Neupro on cardiovascular measures in patients with restless legs syndrome.
XenoPort commenced shipments of Horizant extended-release tablets in the US.
Do these three things make GlaxoSmithKline a good investment?